ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · IEX Real-Time Price · USD
8.02
+0.05 (0.63%)
Mar 27, 2023, 4:30 PM EDT - Market closed
Stock Price Forecast
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CLPT stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 4 | 4 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 7 | 7 | 8 |
Financial Forecast
Revenue This Year
26.43M
from 20.55M
Increased by
28.61%
Revenue Next Year
31.72M
from 26.43M
Increased by
20.02%
EPS This Year
-0.66
from -0.68
EPS Next Year
-0.58
from -0.66
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.35M | 11.22M | 12.83M | 16.30M | 20.55M | 26.43M | 31.72M |
| Revenue Growth | -0.36% | 52.54% | 14.37% | 27.05% | 26.09% | 28.61% | 20.02% |
| EPS | -0.56 | -0.42 | -0.43 | -0.69 | -0.68 | -0.66 | -0.58 |
| EPS Growth | - | - | - | - | - | - | - |
| No. Analysts | - | - | - | - | - | 4 | 3 |
Revenue Forecast
| Revenue | 2023 | 2024 |
|---|---|---|
| High | 27.3M | 32.7M |
| Avg | 26.4M | 31.7M |
| Low | 25.3M | 30.5M |
Revenue Growth
| Revenue Growth | 2023 | 2024 |
|---|---|---|
| High | 32.8%
| 23.6%
|
| Avg | 28.6%
| 20.0%
|
| Low | 23.1%
| 15.3%
|
EPS Forecast
| EPS | 2023 | 2024 |
|---|---|---|
| High | -0.66 | -0.60 |
| Avg | -0.66 | -0.58 |
| Low | -0.66 | -0.56 |
EPS Growth
| EPS Growth | 2023 | 2024 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.